These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8446519)

  • 1. Intracardiac emergency defibrillation for refractory ventricular fibrillation during implantation of cardioverter defibrillators with nonthoracotomy lead systems.
    Pitschner HF; Neuzner J
    Pacing Clin Electrophysiol; 1993 Feb; 16(2):291-6. PubMed ID: 8446519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioverter-defibrillator implantations without thoracotomy: clinical experience with various electrode configurations and defibrillation wave forms of an endocardial/subcutaneous defibrillator system].
    Neuzner J; Huth C; Friedl A; Reinisch P; Pitschner HF; Schlepper M
    Z Kardiol; 1993 Feb; 82(2):99-107. PubMed ID: 8465572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Nonthoracotomy approach to implantation.
    Yee R; Klein GJ; Leitch JW; Guiraudon GM; Guiraudon CM; Jones DL; Norris C
    Circulation; 1992 Jan; 85(1):196-204. PubMed ID: 1728450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. The PCD investigators and participating institutions.
    Saksena S
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):202-7. PubMed ID: 7681572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with an implantable cardioverter defibrillator for spontaneous ventricular fibrillation in dilated cardiomyopathy with very high defibrillation thresholds.
    Tamura K; Abe H; Nagatomo T; Nakashima Y
    J UOEH; 2001 Dec; 23(4):363-8. PubMed ID: 11789138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of nonthoracotomy cardioversion-defibrillation system.
    Hua W; Vohra J; Mond H
    Chin Med J (Engl); 1998 Jul; 111(7):648-51. PubMed ID: 11245056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination biphasic waveform plus sequential pulse defibrillation improves defibrillation efficacy of a nonthoracotomy lead system.
    Exner D; Yee R; Jones DL; Klein GJ; Mehra R
    J Am Coll Cardiol; 1994 Feb; 23(2):317-22. PubMed ID: 8294680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and efficacy of intraoperative defibrillation threshold measured by defibrillation safety margin in 52 patients with implantable cardioverter defibrillator].
    Zhang Y; Yuan KD; Tang BP; Ma YT; Zhang YY; Wang J; Li JX; Zhang JH; Xu GJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):975-8. PubMed ID: 21215224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative emergency defibrillation methods for refractory ventricular fibrillation in a variety of hospital settings.
    Cohen TJ
    Am Heart J; 1993 Oct; 126(4):962-8. PubMed ID: 8213456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators.
    Tullo NG; Saksena S; Krol RB; Mauro AM; Kunecz D
    Am J Cardiol; 1990 Aug; 66(4):411-5. PubMed ID: 2386116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator implanted by nonthoracotomy approach: initial clinical experience with the redesigned transvenous lead system.
    Moore SL; Maloney JD; Edel TB; McGuinn WP; Gohn D; Morant VA; Trohman R; Simmons TW; Wilkoff BL; Castle LW
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1865-9. PubMed ID: 1721190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized evaluation of a nonthoracotomy implantable cardioverter defibrillator lead system. Endotak/PRX Investigator Group.
    Baker JH; Epstein AE; Voshage-Stahl L
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):72-8. PubMed ID: 9121974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of epicardial patches on defibrillation threshold with nonthoracotomy lead configurations.
    Fotuhi PC; Ideker RE; Idriss SF; Callihan RL; Walker RG; Alt EU
    Circulation; 1995 Nov; 92(10):3082-8. PubMed ID: 7586279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonthoracotomy implantation of cardioverter defibrillators: preliminary experience with a defibrillation lead placed at the right ventricular outflow tract.
    Tang AS; Hendry P; Goldstein W; Green MS; Luce M
    Pacing Clin Electrophysiol; 1996 Jun; 19(6):960-4. PubMed ID: 8774827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting of relatively low energy outputs may permit implantation of a nonthoracotomy automatic cardioverter defibrillator system when high energy outputs prove ineffective.
    Winters SL; Casale AS; Inglesby TV; Curwin JH
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1516-8. PubMed ID: 8904546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M; Hammel D; Borggrefe M; Scheld HH; Breithardt G
    Herz; 1994 Oct; 19(5):259-77. PubMed ID: 8001899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.